(Anthrax Reason 3 O O
Vaccine Reason 3 O O
Adsorbed, Reason 3 O O
Adjuvanted) Reason 3 O O
is Reason 3 O O
a Reason 3 O O
combination Reason 3 O O
of Reason 3 O O
[BioThraxÂ®](https://www.emergentbiosolutions.com/wp-content/uploads/2022/01/BioThrax-US-Prescribing-Information.pdf) Reason 3 O O
(also Reason 3 O O
called Reason 3 O O
anthrax Reason 3 O O
vaccine, Reason 3 O O
adsorbed Reason 3 O O
or Reason 3 O O
AVA) Reason 3 O O
and Reason 3 O O
[CPG Reason 3 O O
7909](https://pubmed.ncbi.nlm.nih.gov/22738916/), Reason 3 O O
a Reason 3 O O
synthetic Reason 3 O O
short Reason 3 O O
DNA Reason 3 O O
sequence Reason 3 O O
that Reason 3 O O
is Reason 3 O O
an Reason 3 O O
effective Reason 3 O O
[vaccine Reason 3 O O
adjuvant](https://www.cdc.gov/vaccinesafety/concerns/adjuvants.html), Reason 3 O O
which Reason 3 O O
increases Reason 3 O O
the Reason 3 O O
speed Reason 3 O O
and Reason 3 O O
the Reason 3 O O
degree Reason 3 O O
of Reason 3 O O
the Reason 3 O O
immune Reason 3 O O
response Reason 3 O O
to Reason 3 O O
[Protective Reason 3 O O
Antigen](https://journals.sagepub.com/doi/full/10.1177/2633105520931966), Reason 3 O O
the Reason 3 O O
primary Reason 3 O O
[vaccine Reason 3 O O
antigen](https://medlineplus.gov/vaccines.html). Reason 3 O O
That Reason 3 O O
the Reason 3 O O
U.S. Reason 3 O O
Food Reason 3 O O
and Reason 3 O O
Drug Reason 3 O O
Administration Reason 3 O O
( Reason 3 O O
[FDA](https://www.fda.gov/)) Reason 3 O O
[accepted](https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-announces-fda-acceptance-biologics-license) Reason 3 O O
the Reason 3 O O
Biologics Reason 3 O O
License Reason 3 O O
Application Reason 3 O O
(BLA) Reason 3 O O
for Reason 3 O O
[AV7909](https://www.emergentbiosolutions.com/products-services/pipeline/) Reason 3 O O
in Reason 3 O O
[June Reason 3 O O
2022](https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-announces-fda-acceptance-biologics-license). Reason 3 O O
The Reason 3 O O
BLA Reason 3 O O
submission Reason 3 O O
was Reason 3 O O
completed Reason 3 O O
under Reason 3 O O
contract Reason 3 O O
[HHSO100201600030C](https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-announces-fda-acceptance-biologics-license) Reason 3 O O
for Reason 3 O O
the Reason 3 O O
advanced Reason 3 O O
development Reason 3 O O
and Reason 3 O O
delivery Reason 3 O O
of Reason 3 O O
AV7909, Reason 3 O O
funded Reason 3 O O
by Reason 3 O O
the Reason 3 O O
Biomedical Reason 3 O O
Advanced Reason 3 O O
Research Reason 3 O O
and Reason 3 O O
Development Reason 3 O O
Authority Reason 3 O O
( Reason 3 O O
[BARDA](https://aspr.hhs.gov/AboutASPR/ProgramOffices/BARDA/Pages/default.aspx)), Reason 3 O O
within Reason 3 O O
the Reason 3 O O
Office Reason 3 O O
of Reason 3 O O
the Reason 3 O O
Administration Reason 3 O O
Preparedness Reason 3 O O
and Reason 3 O O
Response Reason 3 O O
( Reason 3 O O
[ASPR](https://aspr.hhs.gov/Pages/Home.aspx)) Reason 3 O O
in Reason 3 O O
the Reason 3 O O
U.S. Reason 3 O O
Department Reason 3 O O
of Reason 3 O O
Health Reason 3 O O
and Reason 3 O O
Human Reason 3 O O
Services Reason 3 O O
( Reason 3 O O
[HHS](https://www.hhs.gov/)). Reason 3 O O
The Reason 3 O O
Company Reason 3 O O
announced Reason 3 O O
the Reason 3 O O
FDA's Reason 3 O O
[Approval](https://www.globenewswire.com/news-release/2023/07/20/2708649/0/en/Emergent-BioSolutions-Receives-U-S-FDA-Approval-of-CYFENDUS-Anthrax-Vaccine-Adsorbed-Adjuvanted-previously-known-as-AV7909-a-Two-Dose-Anthrax-Vaccine-for-Post-Exposure-Prophylaxis-.html) Reason 3 O O
on Reason 3 O O
July Reason 3 O O
20, Reason 3 O O
2023, Reason 3 O O
as Reason 3 O O
a Reason 3 O O
two-dose Reason 3 O O
anthrax Reason 3 O O
vaccine Reason 3 O O
for Reason 3 O O
[Post-Exposure Reason 3 O O
Prophylaxis Reason 3 O O
(PEP) Reason 3 O O
Use](https://hivinfo.nih.gov/understanding-hiv/fact-sheets/post-exposure-prophylaxis-pep#:~:text=Post%2Dexposure%20prophylaxis%20(PEP)%20means%20taking%20HIV%20medicines%20within,used%20only%20in%20emergency%20situations.). Reason 3 O O
AV7909 Reason 3 O O
was Reason 3 O O
[evaluated](https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-announces-fda-acceptance-biologics-license) Reason 3 O O
for Reason 3 O O
post-exposure Reason 3 O O
prophylaxis Reason 3 O O
of Reason 3 O O
disease Reason 3 O O
following Reason 3 O O
suspected Reason 3 O O
or Reason 3 O O
confirmed Reason 3 O O
exposure Reason 3 O O
to Reason 3 O O
Bacillus Reason 3 O O
anthracis Reason 3 O O
in Reason 3 O O
persons Reason 3 O O
18 Reason 3 O O
through Reason 3 O O
65 Reason 3 O O
years Reason 3 O O
of Reason 3 O O
age Reason 3 O O
when Reason 3 O O
administered Reason 3 O O
in Reason 3 O O
conjunction Reason 3 O O
with Reason 3 O O
recommended Reason 3 O O
antibacterial Reason 3 O O
drugs. Reason 3 O O
The Reason 3 O O
approval Reason 3 O O
of Reason 3 O O
CYFENDUS Reason 3 O O
vaccine Reason 3 O O
is Reason 3 O O
symbolic Reason 3 O O
of Reason 3 O O
Emergent's Reason 3 O O
longstanding Reason 3 O O
partnership Reason 3 O O
with Reason 3 O O
the Reason 3 O O
U.S. Reason 3 O O
government Reason 3 O O
and Reason 3 O O
our Reason 3 O O
shared Reason 3 O O
commitment Reason 3 O O
to Reason 3 O O
helping Reason 3 O O
protect Reason 3 O O
public Reason 3 O O
health," Reason 3 O O
said Reason 3 O O
Dr. Reason 3 O O
Kelly Reason 3 O O
Warfield, Reason 3 O O
Emergent's Reason 3 O O
senior Reason 3 O O
vice Reason 3 O O
president Reason 3 O O
of Reason 3 O O
science Reason 3 O O
and Reason 3 O O
development, Reason 3 O O
in Reason 3 O O
a Reason 3 O O
[press Reason 3 O O
release](https://www.biospace.com/article/releases/emer... Reason 3 O O
- Reason 3 O O
No Reason 3 O O
reasons Reason 3 O O
were Reason 3 O O
found Reason 3 O O
in Reason 3 O O
the Reason 3 O O
text Reason 3 O O
